Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on the computational biology market provides in-depth
analysis of segments and sub-segments in the global as well as regional
computational biology market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional computational
biology market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global
computational biology market. According to the report, the global computational
biology market is projected to grow at a CAGR of 21.39% over the forecast
period of 2020-2026.
Computational biology is the
science of using biological data to change with the algorithms which allow the
understanding of the biological systems and relations. Furthermore, it
comprises the implementation and enhancement of the theoretical processes,
mathematical modeling, and techniques of computational simulation to study the
biological, social, and behavioral systems. Computational biology finds its
application in preclinical drug development, human body simulation software,
and several others. Moreover, the usage of computational biology has heightened
for gene sequencing and expansion, protein transcription, structural and
functional epigenomic, genomics, and metagenomics for the exploration of
protein-protein interactions, and 3-D protein structure analysis.
Factors that are responsible for
the growth of the computational biology market include an increase in
bioinformatics research, a growing number of clinical studies in
pharmacogenomics and pharmacokinetics, and the development of drug designing
and disease modeling. Furthermore, the increasing focus of the pharmaceutical
industry to speed up development and improve the accuracy in drug development
will facilitate the adoption of computational biology. Also, the increasing
prevalence of cancer is expected to promote the adoption of computational
biology in oncology therapeutics. In addition, increasing investments in
computational biology research are projected to offer lucrative opportunities
for the growth of the market. Augmented funding in bioinformatics is helping in
creating more development in the field of computational biology. However, a
grave shortage of skilled professionals may hamper the growth of the
computational biology market.
Additionally, the current concern
over the spread of coronavirus is also expected to have a positive impact on
the computational biology market. Computational biology and bioinformatics play
a key role in virology and helps in understanding the spread of virus
epidemics, and the origin and evolution of viruses, the structure, functioning,
and interfaces of viral molecules, the within-host dynamics of virus
infections, and the effect and optimum design of human interventions from drug
discovery to pandemic control. Moreover, computational biology can also help
with the design of a vaccine for Sars-CoV-2. The mathematical modeling of viral
evolution helps in understanding how a virus evolves to escape the immune
system, which will greatly help in designing a vaccine for the virus.
Researchers worldwide are gathering genetic information about Sars-CoV-2 as it
spreads, building the data set that is required for us to better understand how
this virus changes. This will be a crucial piece of information for the vaccine
manufacturers who are involved in developing vaccines against COVID-19, by the
time a vaccine is ready for mass production. Computational biology will help
speed up and streamline the drug discovery process.
Among the geographies, the North
America region is expected to hold the largest share in the global
computational biology market. The industry is expected to offer huge
opportunities for market growth on account of the presence of several key
players. North America leads the global computational biology market share with
cumulative initiatives and investments for R&D of new drugs, drug
discovery, technological advancements, and disease modeling in biological
computations. Furthermore, the Asia Pacific region is expected to witness high
growth in the global computational biology market during the forecast period.
The increasing government-funded population-based studies and foreign investments
in China, Japan, India, and East Asian countries are anticipated to provide
positive opportunities for the market across the region.
The report on global computational
biology market covers segments such as application, service, and end user. On
the basis of application, the sub-markets include human body simulation
software, preclinical drug development, cellular & biological simulation,
clinical trials, drug discovery, and disease modelling. On the basis of
service, the sub-markets include in-house, and contract. On the basis of end
user, the sub-markets include academics, and commercial.
The report provides profiles of
the companies in the market such as Chemical Computing Group Inc., Genedata AG,
Nimbus Discovery Llc, Simulation Plus Inc, Dassault Systemes, Compugen Ltd,
Rosa & Co. LLC, Insilico Biotechnology AG, Schrodinger, and Leadscope Inc.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of computational biology market. Moreover, the study highlights
current market trends and provides forecast from 2020-2026. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.